BPC-157 addresses the gut-skin connection that topical routines can't touch — reducing systemic inflammation, accelerating tissue healing, and supporting skin from the inside out.
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It has one of the most robust research profiles of any peptide, with studies spanning gut healing, soft-tissue repair, tendon regeneration, and anti-inflammatory effects. At Lustre, we position it primarily around the gut-skin axis — the increasingly well-understood connection between gut health and skin quality.
BPC-157 upregulates nitric oxide synthesis, accelerates angiogenesis (new blood vessel formation), and modulates inflammatory signalling pathways. In the gut, it accelerates mucosal healing and reduces permeability — directly impacting systemic inflammation levels that show up in the skin as texture irregularities, redness, and accelerated aging.
Women dealing with inflammatory skin conditions, post-antibiotic gut disruption, chronic low-grade inflammation, or seeking accelerated tissue recovery.
The Repair Protocol is pending FDA 503A reclassification at the PCAC meeting on July 23–24, 2026. Join the waitlist and we'll notify you the moment your provider can prescribe.
The gut-skin axis refers to the bidirectional relationship between gut health and skin condition. Intestinal permeability and dysbiosis both contribute to systemic inflammation, which manifests visibly in the skin. BPC-157 addresses this upstream.
Yes — this is one of our most anticipated stacks. GHK-Cu addresses collagen and dermal structure while BPC-157 works on the inflammatory and gut-skin dimension. Your provider will advise on timing.
Yes. Complete the intake flow and select The Repair Protocol as your primary interest. You'll be first to know when it's available.
Compounded peptides are prescribed off-label for wellness, performance, and recovery goals under the supervision of a licensed medical provider. They are not intended to diagnose, treat, cure, or prevent any disease.
All peptides dispensed by Lustre Health are prescription-only medications requiring a valid prescription from a licensed provider.
Compounded medications are not FDA-approved drug products. They are prepared by state-licensed 503A compounding pharmacies under USP Chapter 797 standards.
Peptides may interact with insulin, hormone therapies, and immunosuppressants. Disclose all medications to your provider.
Subcutaneous injection. Full training provided with your first shipment.